2008
DOI: 10.1038/gt.2008.105
|View full text |Cite
|
Sign up to set email alerts
|

Gene therapy progress and prospects: synthetic polymer-based systems

Abstract: Low efficiency, significant toxicity, polymer polydispersity and poorly understood delivery mechanisms have initially plagued the field of polymer-based gene therapy. Numerous strategies have helped to improve polyplexes, including the development of biodegradable polymers with reduced toxicity, incorporation of cell targeting, surface shielding and additional transport domains for effective and specific delivery, or improved chemistry for syntheses of polymers with uniform size and topology. Combined biooptic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
189
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 269 publications
(190 citation statements)
references
References 59 publications
(80 reference statements)
1
189
0
Order By: Relevance
“…The use of synthetic materials, such as polymers, for polynucleotide delivery has rapidly grown, and presents a wealth of promising alternatives to conventional viral vectors (3)(4)(5), which have caused serious problems in the clinic. Although much is known about the infection pathways, advantages, and troubles of viral vectors (6), researchers in the field of nonviral delivery are just beginning to understand the transfection mechanisms, benefits, and potential issues with the multitude of materials being developed as macromolecular drug carriers (7,8).…”
mentioning
confidence: 99%
“…The use of synthetic materials, such as polymers, for polynucleotide delivery has rapidly grown, and presents a wealth of promising alternatives to conventional viral vectors (3)(4)(5), which have caused serious problems in the clinic. Although much is known about the infection pathways, advantages, and troubles of viral vectors (6), researchers in the field of nonviral delivery are just beginning to understand the transfection mechanisms, benefits, and potential issues with the multitude of materials being developed as macromolecular drug carriers (7,8).…”
mentioning
confidence: 99%
“…A relatively high activity of Turbofect, which is poly(2-hydroxypropyleneimine) [30], could be explained by its ability to efficiently condense pDNA and promote its intracellular release from lysosomes due to their disruption by the cationic polymer ('proton sponge' effect). However, such characteristics of cationic polymers contribute to their high cytotoxicity [2,7], indicating the need to develop different polymeric systems for gene delivery. Our results demonstrate that TFCs can be used to enhance the transfection of human cells, presumably by promoting cellular uptake of pDNA complexes.…”
Section: Effect Of Trifunctional Copolymers On Transfection Of Human mentioning
confidence: 99%
“…The main engineering platforms for gene therapeutics include synthetic oligonucleotides, viruses and plasmid DNAs (pDNA) [1,2], the two latter types are considered 'pro-drugs' that allow for a template-directed synthesis of a desired peptide within the cell. Compared to viruses, pDNA has a great advantage in clinical application due to its intrinsic safety, low cost and vector capacity.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations